The Triglyceride Lowering Effect of an Omega-3 Fat (DHA) in Addition to Statin Therapy for Patients With CAD or Diabetes

NCT00360217 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Hypertriglyceridemia (TG>200<500)
Hyperlipidemia
Coronary Artery Disease
Coronary Risk Equivalent
Diabetes

Interventions

DRUG: docosahexanoic acid (DHA)

Sponsor

Maine Center for Lipids and Cardiovascular Health